Bcl-2 oncoprotein expression and apoptosis in neuroblastoma

Area of Science:

• Oncology
• Molecular Biology
• Cell Biology

Background:

• The bcl-2 protooncogene, identified at the t(14;18) chromosomal breakpoint, regulates apoptosis.
• Inhibition of apoptosis is a key factor in tumor development.
• Neuroblastomas are common childhood cancers originating from immature nerve cells.

Purpose of the Study:

• To investigate the association between bcl-2 protooncogene expression and neuroblastoma tumorigenesis.
• To determine if bcl-2 expression correlates with clinical features of neuroblastoma.
• To examine the relationship between bcl-2 expression and apoptosis in neuroblastomas.

Main Methods:

• Immunohistochemistry was used to detect bcl-2 oncoprotein in 49 neuroblastomas and 7 ganglioneuromas.
• The TUNEL method was employed to identify apoptotic cells within the tumors.
• Serial sections were analyzed to correlate bcl-2 expression with apoptotic cell distribution.

Main Results:

• Bcl-2 oncoprotein was detected in 81.6% of neuroblastomas, but only 28.6% of ganglioneuromas.
• No correlation was found between bcl-2 expression and clinical features of neuroblastoma.
• Apoptotic cells (TUNEL-positive) were observed in 32.4% of neuroblastomas, often near calcifications in younger patients.
• Apoptotic cells were frequently located in areas lacking bcl-2 expression.

Conclusions:

• Bcl-2 expression appears to regulate apoptosis in neuroblastoma cells.
• Increased bcl-2 expression may promote the survival of neuroblastoma cells.
• The findings suggest bcl-2 protooncogene is associated with the tumorigenesis of neuroblastomas.